Equities Analysts Offer Predictions for PAHC Q1 Earnings

Phibro Animal Health Co. (NASDAQ:PAHCFree Report) – Equities research analysts at Zacks Research dropped their Q1 2026 earnings per share (EPS) estimates for shares of Phibro Animal Health in a research note issued on Thursday, November 28th. Zacks Research analyst R. Department now expects that the company will post earnings of $0.31 per share for the quarter, down from their prior estimate of $0.32. The consensus estimate for Phibro Animal Health’s current full-year earnings is $1.61 per share. Zacks Research also issued estimates for Phibro Animal Health’s Q2 2026 earnings at $0.47 EPS, Q4 2026 earnings at $0.49 EPS and FY2026 earnings at $1.60 EPS.

A number of other research firms have also commented on PAHC. Barclays boosted their price target on shares of Phibro Animal Health from $13.00 to $20.00 and gave the company an “underweight” rating in a research report on Tuesday, November 12th. Bank of America raised their target price on shares of Phibro Animal Health from $13.00 to $15.00 and gave the company an “underperform” rating in a research note on Friday, August 30th. JPMorgan Chase & Co. started coverage on shares of Phibro Animal Health in a report on Tuesday, September 10th. They issued a “neutral” rating and a $22.00 price target on the stock. Finally, StockNews.com upgraded shares of Phibro Animal Health from a “buy” rating to a “strong-buy” rating in a research report on Thursday, November 28th. Three analysts have rated the stock with a sell rating, one has given a hold rating and one has issued a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average price target of $16.50.

Get Our Latest Report on Phibro Animal Health

Phibro Animal Health Trading Down 1.2 %

Shares of PAHC opened at $23.26 on Monday. The business’s 50-day moving average price is $23.37 and its 200-day moving average price is $20.30. The company has a quick ratio of 1.69, a current ratio of 3.23 and a debt-to-equity ratio of 1.81. The stock has a market cap of $942.03 million, a PE ratio of 54.09, a P/E/G ratio of 0.61 and a beta of 0.51. Phibro Animal Health has a twelve month low of $9.94 and a twelve month high of $25.98.

Phibro Animal Health Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, December 18th. Stockholders of record on Wednesday, November 27th will be paid a $0.12 dividend. The ex-dividend date of this dividend is Wednesday, November 27th. This represents a $0.48 dividend on an annualized basis and a dividend yield of 2.06%. Phibro Animal Health’s dividend payout ratio (DPR) is 111.63%.

Institutional Inflows and Outflows

Large investors have recently modified their holdings of the stock. CWM LLC grew its position in Phibro Animal Health by 89.8% during the 2nd quarter. CWM LLC now owns 2,188 shares of the company’s stock worth $37,000 after acquiring an additional 1,035 shares during the last quarter. Quantbot Technologies LP purchased a new stake in shares of Phibro Animal Health during the third quarter valued at approximately $70,000. nVerses Capital LLC bought a new position in shares of Phibro Animal Health in the third quarter worth approximately $70,000. China Universal Asset Management Co. Ltd. increased its stake in shares of Phibro Animal Health by 63.7% in the third quarter. China Universal Asset Management Co. Ltd. now owns 3,912 shares of the company’s stock worth $88,000 after buying an additional 1,522 shares during the period. Finally, Summit Securities Group LLC bought a new stake in Phibro Animal Health during the 2nd quarter valued at $83,000. Hedge funds and other institutional investors own 99.34% of the company’s stock.

About Phibro Animal Health

(Get Free Report)

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.

Featured Articles

Earnings History and Estimates for Phibro Animal Health (NASDAQ:PAHC)

Receive News & Ratings for Phibro Animal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phibro Animal Health and related companies with MarketBeat.com's FREE daily email newsletter.